Anebulo Pharmaceuticals, Inc. (ANEB) Press Releases https://ir.anebulo.com/news-events/press-releases/rss en-us https://d1io3yog0oux5.cloudfront.net/anebulo/files/theme/images/logo-sm.png Anebulo Pharmaceuticals, Inc. Logo Equisolve Investor Relations Suite <![CDATA[Anebulo Pharmaceuticals Reports Second Quarter Fiscal Year 2026 Financial Results and Recent Updates]]> https://ir.anebulo.com/news-events/press-releases/detail/95/anebulo-pharmaceuticals-reports-second-quarter-fiscal-year Thu, 12 Feb 26 16:15:00 -0500 https://ir.anebulo.com/news-events/press-releases/detail/95/anebulo-pharmaceuticals-reports-second-quarter-fiscal-year <![CDATA[Anebulo Pharmaceuticals Announces Intention to Voluntarily Delist from Nasdaq and Deregister with SEC]]> https://ir.anebulo.com/news-events/press-releases/detail/94/anebulo-pharmaceuticals-announces-intention-to-voluntarily Fri, 06 Feb 26 09:00:00 -0500 https://ir.anebulo.com/news-events/press-releases/detail/94/anebulo-pharmaceuticals-announces-intention-to-voluntarily <![CDATA[Anebulo Pharmaceuticals Announces Final Results of Tender Offer]]> https://ir.anebulo.com/news-events/press-releases/detail/93/anebulo-pharmaceuticals-announces-final-results-of-tender Thu, 29 Jan 26 09:00:00 -0500 https://ir.anebulo.com/news-events/press-releases/detail/93/anebulo-pharmaceuticals-announces-final-results-of-tender <![CDATA[Anebulo Pharmaceuticals Announces Preliminary Results of Tender Offer]]> https://ir.anebulo.com/news-events/press-releases/detail/92/anebulo-pharmaceuticals-announces-preliminary-results-of Tue, 27 Jan 26 09:00:00 -0500 https://ir.anebulo.com/news-events/press-releases/detail/92/anebulo-pharmaceuticals-announces-preliminary-results-of <![CDATA[Anebulo Pharmaceuticals Announces Its Intent to Commence a Self Tender Offer]]> https://ir.anebulo.com/news-events/press-releases/detail/91/anebulo-pharmaceuticals-announces-its-intent-to-commence-a Mon, 22 Dec 25 09:00:00 -0500 https://ir.anebulo.com/news-events/press-releases/detail/91/anebulo-pharmaceuticals-announces-its-intent-to-commence-a <![CDATA[Anebulo Pharmaceuticals Reports First Quarter Fiscal Year 2026 Financial Results and Recent Updates]]> https://ir.anebulo.com/news-events/press-releases/detail/90/anebulo-pharmaceuticals-reports-first-quarter-fiscal-year Thu, 13 Nov 25 16:05:00 -0500 https://ir.anebulo.com/news-events/press-releases/detail/90/anebulo-pharmaceuticals-reports-first-quarter-fiscal-year <![CDATA[Anebulo Pharmaceuticals Reports Fourth Quarter and Fiscal Year 2025 Financial Results and Recent Updates]]> https://ir.anebulo.com/news-events/press-releases/detail/89/anebulo-pharmaceuticals-reports-fourth-quarter-and-fiscal Mon, 29 Sep 25 16:05:00 -0400 https://ir.anebulo.com/news-events/press-releases/detail/89/anebulo-pharmaceuticals-reports-fourth-quarter-and-fiscal <![CDATA[Anebulo Pharmaceuticals Announces First Patients Dosed in Phase 1 Single Ascending Dose Study of Intravenous Selonabant, under Development for Acute Cannabis-Induced Toxicity]]> https://ir.anebulo.com/news-events/press-releases/detail/88/anebulo-pharmaceuticals-announces-first-patients-dosed-in Thu, 25 Sep 25 07:30:00 -0400 https://ir.anebulo.com/news-events/press-releases/detail/88/anebulo-pharmaceuticals-announces-first-patients-dosed-in <![CDATA[Anebulo Pharmaceuticals Announces Update on Going Private Transaction and Strategic Alternatives]]> https://ir.anebulo.com/news-events/press-releases/detail/87/anebulo-pharmaceuticals-announces-update-on-going-private Fri, 12 Sep 25 07:30:00 -0400 https://ir.anebulo.com/news-events/press-releases/detail/87/anebulo-pharmaceuticals-announces-update-on-going-private <![CDATA[Anebulo Pharmaceuticals Approves Plan to Terminate Registration of Its Common Stock]]> https://ir.anebulo.com/news-events/press-releases/detail/86/anebulo-pharmaceuticals-approves-plan-to-terminate Wed, 23 Jul 25 08:00:00 -0400 https://ir.anebulo.com/news-events/press-releases/detail/86/anebulo-pharmaceuticals-approves-plan-to-terminate